Interleukin‐receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Interleukin‐receptor Antagonist and Tumour Necrosis Factor Inhibitors for the Primary and Secondary Prevention of Atherosclerotic Cardiovascular Diseases." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumour_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases.
Interleukin‐receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumour_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases. Accessed February 9, 2025.
Interleukin‐receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumour_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases
Interleukin‐receptor Antagonist and Tumour Necrosis Factor Inhibitors for the Primary and Secondary Prevention of Atherosclerotic Cardiovascular Diseases [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumour_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Interleukin‐receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases
ID - 435877
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435877/all/Interleukin‐receptor_antagonist_and_tumour_necrosis_factor_inhibitors_for_the_primary_and_secondary_prevention_of_atherosclerotic_cardiovascular_diseases
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -